logo

[breadcrumb_custom]

ALDX’s Stochastic Averages Dip: Analyzing Aldeyra Therapeutics Inc’s Stock Performance

The market performance of Aldeyra Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $11.97 on 06/15/23, with the lowest value for the same timeframe being $1.42, recorded on 10/16/23.

52-week price history of ALDX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Aldeyra Therapeutics Inc’s current trading price is -70.34% away from its 52-week high, while its distance from the 52-week low is 150.00%. The stock’s price range for this period has remained between $1.42 and $11.97. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.06 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.5 million over the last three months.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Financial Performance and Market Capitalization

Aldeyra Therapeutics Inc (ALDX) has experienced a quarterly rise of 1.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 209.09M and boasts a workforce of 10 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.16, with a change in price of +1.30. Similarly, Aldeyra Therapeutics Inc recorded 936,967 in trading volume during the last 100 days, posting a change of +57.78%.

ALDX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ALDX stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.00.

ALDX Stock Stochastic Average

As of today, the raw stochastic average of Aldeyra Therapeutics Inc over the past 50 days is 51.53%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 58.33%. Additionally, the Stochastic %K and %D values for the company were 42.71% and 35.97%, respectively, over the past 20 days.

ALDX Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 1.14%. However, over the past six months, we’ve seen a stronger performance of -46.86%. The price of ALDX leaped by -15.88% over the last 30 days. And in the last five days, it has surged by 23.26%.

On Key

Related Posts